Skip to content

Clinical trials

Phase 1/2 Carcinoma, Intraductal, Noninfiltrating trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Intraductal, Noninfiltrating Phase: Phase 1/2 Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20092
20111
20141
20151
20191
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abramson Cancer Center at Penn Medicine1
Eli Avisar, MD1
Georgetown University1
H. Lee Moffitt Cancer Center and Research Institute1
Inova Health Care Services1
Integro Theranostics1
NYU Langone Health1
University of California, San Francisco1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Intraductal, Noninfiltrating8
Breast Neoplasms7
Breast Carcinoma In Situ1
Carcinoma, Ductal, Breast1

Trials

Showing 26 to 8 of 8. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.